System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain

Purpose of the study. Studying the components of the cascade of plasminogen (PG) regulator in the skin of intact uPA (urokinase plasminogen activator) gene-knockout mice and in a model of chronic neurogenic pain (CNP).Materials and methods. The study included 76 mice divided in groups depending on t...

Full description

Saved in:
Bibliographic Details
Main Authors: E. M. Frantsiyants, E. I. Surikova, I. V. Kaplieva, I. V. Neskubina, L. S. Kozlova, V. A. Bandovkina, L. K. Trepitaki, V. V. Pozdnyakova
Format: Article
Language:Russian
Published: QUASAR, LLC 2019-12-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/459
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025062282821632
author E. M. Frantsiyants
E. I. Surikova
I. V. Kaplieva
I. V. Neskubina
L. S. Kozlova
V. A. Bandovkina
L. K. Trepitaki
V. V. Pozdnyakova
author_facet E. M. Frantsiyants
E. I. Surikova
I. V. Kaplieva
I. V. Neskubina
L. S. Kozlova
V. A. Bandovkina
L. K. Trepitaki
V. V. Pozdnyakova
author_sort E. M. Frantsiyants
collection DOAJ
description Purpose of the study. Studying the components of the cascade of plasminogen (PG) regulator in the skin of intact uPA (urokinase plasminogen activator) gene-knockout mice and in a model of chronic neurogenic pain (CNP).Materials and methods. The study included 76 mice divided in groups depending on the gender, presence or absence of uPA gene knockout and CNP. A CNP model was created by sciatic nerve ligation; levels and activity of components of PG activation cascade were studied by ELISA using standard test systems.Results. Intact uPA-deficient C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu mice differed from C57BL/6 mice by a decreased level of PG regulators, excluding plasmin in all mice, PG in males and urokinase receptor (uPAR). uPA-deficient mice with CNP showed continuing decrease in levels of plasminogen regulators, except for uPAR in all mice, PG in males and the activity of plasminogen activator inhibitor-1 (PAI-1-act) in females.Conclusion. Almost the entire cascade of PG regulators was inhibited in intact uPA-deficient mice of both genders, compared to C57BL/6 animals, except for uPAR in females, PG in males and plasmin in all animals. In CNP, PG regulators in uPA-deficient mice were inhibited compared to the background, excluding uPAR in males and females. The comparison with C57BL/6 mice demonstrated that the CNP model resulted in the uPA system state very similar to that in intact uPA-deficient C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu animals. In C57BL/6 mice with CNP, levels of uPA were reduced by 2 orders of magnitude, relative to the norm, with the almost complete depletion of uPA activity. uPA gene knockout results in a persistent suppression of the system of PG regulators which is practically not affected by CNP, except for the uPAR level, and causes changes similar to that in the CNP modeling in normal mice.
format Article
id doaj-art-964d571f78ca452e8714f6b9e161adac
institution DOAJ
issn 2410-1893
language Russian
publishDate 2019-12-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-964d571f78ca452e8714f6b9e161adac2025-08-20T03:00:57ZrusQUASAR, LLCИсследования и практика в медицине2410-18932019-12-0164243310.17709/2409-2231-2019-6-4-2290System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic painE. M. Frantsiyants0E. I. Surikova1I. V. Kaplieva2I. V. Neskubina3L. S. Kozlova4V. A. Bandovkina5L. K. Trepitaki6V. V. Pozdnyakova7Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Rostov Research Institute of Oncology (RRIO)Purpose of the study. Studying the components of the cascade of plasminogen (PG) regulator in the skin of intact uPA (urokinase plasminogen activator) gene-knockout mice and in a model of chronic neurogenic pain (CNP).Materials and methods. The study included 76 mice divided in groups depending on the gender, presence or absence of uPA gene knockout and CNP. A CNP model was created by sciatic nerve ligation; levels and activity of components of PG activation cascade were studied by ELISA using standard test systems.Results. Intact uPA-deficient C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu mice differed from C57BL/6 mice by a decreased level of PG regulators, excluding plasmin in all mice, PG in males and urokinase receptor (uPAR). uPA-deficient mice with CNP showed continuing decrease in levels of plasminogen regulators, except for uPAR in all mice, PG in males and the activity of plasminogen activator inhibitor-1 (PAI-1-act) in females.Conclusion. Almost the entire cascade of PG regulators was inhibited in intact uPA-deficient mice of both genders, compared to C57BL/6 animals, except for uPAR in females, PG in males and plasmin in all animals. In CNP, PG regulators in uPA-deficient mice were inhibited compared to the background, excluding uPAR in males and females. The comparison with C57BL/6 mice demonstrated that the CNP model resulted in the uPA system state very similar to that in intact uPA-deficient C57BL/6-PlautmI.IBug-ThisPlau6FDhu/GFDhu animals. In C57BL/6 mice with CNP, levels of uPA were reduced by 2 orders of magnitude, relative to the norm, with the almost complete depletion of uPA activity. uPA gene knockout results in a persistent suppression of the system of PG regulators which is practically not affected by CNP, except for the uPAR level, and causes changes similar to that in the CNP modeling in normal mice.https://www.rpmj.ru/rpmj/article/view/459upa-deficient miceplasminogen regulatorschronic neurogenic pain
spellingShingle E. M. Frantsiyants
E. I. Surikova
I. V. Kaplieva
I. V. Neskubina
L. S. Kozlova
V. A. Bandovkina
L. K. Trepitaki
V. V. Pozdnyakova
System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
Исследования и практика в медицине
upa-deficient mice
plasminogen regulators
chronic neurogenic pain
title System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
title_full System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
title_fullStr System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
title_full_unstemmed System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
title_short System of plasminogen regulators in the skin of intact uPA gene-knockout C57BL/6-PlautmI.IBug-This Plau6FDhu/GFDhu mice and in a model of chronic neurogenic pain
title_sort system of plasminogen regulators in the skin of intact upa gene knockout c57bl 6 plautmi ibug this plau6fdhu gfdhu mice and in a model of chronic neurogenic pain
topic upa-deficient mice
plasminogen regulators
chronic neurogenic pain
url https://www.rpmj.ru/rpmj/article/view/459
work_keys_str_mv AT emfrantsiyants systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT eisurikova systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT ivkaplieva systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT ivneskubina systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT lskozlova systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT vabandovkina systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT lktrepitaki systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain
AT vvpozdnyakova systemofplasminogenregulatorsintheskinofintactupageneknockoutc57bl6plautmiibugthisplau6fdhugfdhumiceandinamodelofchronicneurogenicpain